CYBB and urinary bladder cancer: ROS and inflammatory response are closely related to tumorigenesis and development, and inhibition of NOX2 can limit the occurrence of inflammation and the generation of ROS, but there is no literature report on inhibiting NOX2 to delay the occurrence and development of arsenic-induced bladder cancer.